We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.00 | 0.92% | 1,651.00 | 1,650.50 | 1,651.50 | 1,656.00 | 1,635.00 | 1,642.00 | 1,023,492 | 11:02:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.72 | 67.62B |
Date | Subject | Author | Discuss |
---|---|---|---|
03/1/2019 08:31 | lol, you mean one of the BBC's lot, all talk and no useful information? | gbh2 | |
03/1/2019 08:25 | Monty, were you a weather forecaster in your previous life? | jadeticl3 | |
03/1/2019 07:59 | Yes dump the FANG stocks Apple etc.Buy pharmaceuticals. | montyhedge | |
02/1/2019 14:59 | After a poor few weeks showing some good defensive qualities again. Market may be waking up to the fact that GSK has got some fire in its belly again! | rikky72 | |
02/1/2019 13:27 | "if I were a woman at the top" ,in this case we will not need the blue tablet ! | abdullla | |
01/1/2019 12:33 | No...I just don't like their brand of bigotry and hatred. As we all know, these are Mail specialties. | zicopele | |
31/12/2018 22:10 | I too will be happy to receive the January divided, happier still with the April dividend, but happiest of all if all four were equal to April dividend!! Hope springs eternal. | jadeticl3 | |
31/12/2018 16:00 | Classy way to end the year. You must be very proud. | oriana2 | |
31/12/2018 12:07 | Fantastic....but the share is falling. Beats the Hate Mail though | zicopele | |
31/12/2018 11:34 | That will do me, pass go and collect dividends every 13 weeks while we wait for target price 1900p.My share of the year. | montyhedge | |
31/12/2018 11:19 | I prefer these tips: GlaxoSmithKline (LON:GSK) has been assigned a GBX 1,900 ($24.83) price target by research analysts at Goldman Sachs Group in a research report issued on Monday. The firm currently has a “buy” rating on the stock. Goldman Sachs Group’s price target points to a potential upside of 26.08% from the company’s previous close. | tradermichael | |
31/12/2018 08:02 | Is that the same Daily Mail which is pumping the pharma minnow Motif? Reckons stock will treble in the next month. Now where is my broker? | zicopele | |
30/12/2018 18:41 | GSK Daily Mail share for 2019. | montyhedge | |
30/12/2018 09:32 | I think the dividend for the pharma/vaccines group will stay the same (pro rata), and debt will shift to the consumer healthcare group, leaving the dividend there exposed. Here's what an expert thinks: The separation will take away the steady cash flows of the consumer business, meaning there’s more pressure on the men and women in white coats to deliver the next generation of blockbusters. However, the potential to shift significant amounts of debt onto the cash generative consumer business should take the strain off the balance sheet, and thus buy valuable time for the pipeline to deliver. George Salmon Equity Analyst, Hargreaves Lansdown | tradermichael | |
30/12/2018 09:16 | I wonder if the split companies will maintain the same level of dividend? Is this a divi cut in disguise? A rhetorical question. No difference, Im sticking with pharma, they are the biggest holdings in my portfolio. | escapetohome | |
30/12/2018 08:44 | Don't worry, I'm the No.1 trader. GSK is a tuckaway not for trading. GSK will be a big winner and collect a 80p dividend while you wait for 2075p. | montyhedge | |
29/12/2018 16:51 | lol, before I Filtered the nutter I used him as a guide, generally doing well betting against his advice. Judging by your comment I guess things haven't changed much since 2015. | gbh2 | |
29/12/2018 16:04 | Monty, you know that your reputation on this site is so high that everyone will now expect GSK to be the best share in FTSE IN 2019. I just hope you are not wrong for the first time! | jadeticl3 | |
29/12/2018 14:51 | A merger or takeover perhaps with AZN once GSK split up? I hold both. Nice. | escapetohome | |
29/12/2018 14:25 | I think could be the share of the FTSE 100 in 2019.Plus 80p dividend. | montyhedge | |
28/12/2018 23:11 | buywell3, can you list the sites on which you propagate your info, please? | jadeticl3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions